Rocket Lab's Two-Sided Story: Record Backlog Meets a Market That's Not Celebrating
Published on 08/27/2026 at 08:12 | Editorial boerse-global.de
The disconnect could hardly be starker. Rocket Lab is stacking up government contracts, launching missions at a brisk clip, and watching its order book swell to levels it has never seen before. Yet the share price keeps sliding, and the latest dip — a 9.0 percent weekly decline that left the stock at 56.90 euros — has investors asking whether the market is pricing in something the operational numbers aren't showing.
That tension between momentum and skepticism is the defining feature of Rocket Lab's current chapter. The company just completed its 93rd Electron mission on August 20, delivering an Earth-observation satellite for Japan's iQPS institute into low-Earth orbit from its New Zealand launch site. Days earlier, it had been admitted into the US Space Force's Space Data Network Consortium, a move accompanied by two delivery orders worth a combined 12 million dollars for optical communications testing using the Photon platform. Viasat has also tapped Rocket Lab to build a satellite bus on the Lightning-GEO platform for a Space Force program, and the company has been folded into the NITE-STAR framework agreement, a contract vehicle with a program volume of up to 981 million dollars.
A Backlog That's More Than Doubled
The cumulative effect of this contract density is a backlog that has grown 137 percent year over year to 2.36 billion dollars. For a company whose revenue stream still leans heavily on individual large awards, that kind of pipeline growth is a tangible signal of future sales — even if it doesn't yet translate into profits. The second quarter told a similar story on the top line: revenue of 234.07 million dollars came in ahead of the 231.62 million dollar consensus estimate, while the per-share loss of 0.08 dollars was wider than the 0.06 dollars analysts had penciled in.
Seeking Alpha took note, upgrading the stock to "Buy" on August 22. The research service pointed to a significantly improved margin of safety following the recent pullback, alongside that record backlog. But not everyone is convinced. Wall Street Zen downgraded Rocket Lab from "Hold" to "Sell" on August 15, citing the broader-than-expected adjusted loss and elevated valuation multiples. On the same day, Pluang raised its price target to 209 dollars and reaffirmed "Buy," leaning on the record second-quarter revenue and faster-than-anticipated expansion of vertically integrated infrastructure. The divergence captures just how differently analysts weigh growth potential against operational losses.
Insider Sales: Routine Mechanics, Not a Red Flag
Adding to the noise, a wave of insider selling hit the tape in late August. Chief Operating Officer Frank Klein disposed of 45,692 shares worth roughly 3.18 million dollars on August 24, while President Marvin Bradford Clevenger sold 15,051 shares for about 1.05 million dollars. CFO Adam C. Spice offloaded 9,677 shares, and Senior Vice President Arjun Kampani sold 7,754 shares.
Just as Rocket Lab's insiders are managing their personal risk, every business faces its own hidden liabilities — especially when it comes to workplace safety. Many employers underestimate how vulnerable they are without properly documented risk assessments. A free toolkit with 41 ready-to-use templates and checklists helps you identify hazards and protect your workforce before problems escalate. Download the free Risk Assessment Toolkit
The context matters more than the raw numbers. All of these were "sell-to-cover" transactions, executed to settle tax liabilities arising from the vesting of restricted stock units — a routine administrative process, not a statement of lost faith. Spice's sales, for instance, ran through a Rule 10b5-1 plan established well in advance, and he still holds 1,155,967 shares worth around 80.49 million dollars. That level of skin in the game is hardly the profile of an executive rushing for the exit.
The market, however, reacted nervously to the disclosures, with the stock slipping 1.1 percent to 66.18 dollars at one point. That jitteriness fits a broader pattern: the space sector has been under pressure since the explosion of Blue Origin's New Glenn rocket in May and a lowered valuation expectation for SpaceX's eventual IPO. Rocket Lab shares fell 15 percent in a single session alongside other space names like Intuitive Machines and Redwire, prompting analysts to warn of a bubble in space equities, with some valuations reaching more than 90 times annual revenue.
The Iridium Deal Looms Large
The next major catalyst is the planned acquisition of Iridium Communications. The waiting period under the Hart-Scott-Rodino Act has expired, and Rocket Lab has filed applications with the FCC to transfer Iridium's licenses. Iridium shareholders are scheduled to vote on the merger on September 24 — a date that could reshape the company's strategic trajectory. The Iridium business, with its 2.5 million subscribers, represents the kind of recurring revenue that would extend Rocket Lab well beyond its launch-vehicle roots, complementing the satellite manufacturing and platform technology it has been building out.
Technically, the stock is trading roughly 18 percent below its 50-day average, with an RSI of 35.3 pointing to oversold conditions. The 30-day volatility reading of 72 percent underscores just how bumpy the ride has been. The consensus among analysts remains "Moderate Buy" with an average price target of 110.65 dollars — well above current levels — suggesting the professional view hasn't been fundamentally shaken by the insider sales or the sector turbulence.
All eyes now turn to November 9, when Rocket Lab reports third-quarter results. Management has guided for revenue between 250 and 265 million dollars, a range that will test whether the operational momentum can convert into sustainable growth — or whether the skeptics have been reading the tea leaves correctly all along.
